You just read:

Axovant Sciences Announces Preliminary Results from Interim Analysis of Phase 2 Study Testing Investigational Drug Nelotanserin in Lewy Body Dementia Patients

News provided by

Axovant Sciences

Feb 13, 2017, 07:00 ET